TY - JOUR
T1 - Microencapsulation of human growth hormone within biodegradable polyester microspheres
T2 - Protein aggregation stability and incomplete release mechanism
AU - Kim, Hong Kee
AU - Park, Tae Gwan
PY - 1999/12/20
Y1 - 1999/12/20
N2 - Recombinant human growth hormone (rhGH) was encapsulated within poly(D,L-lactic-co-glycolic acid) microspheres by a double emulsion solvent evaporation method. A mixture of methylene chloride and ethyl acetate in varying volume ratios was used for the micro-sphere preparation. Protein release profiles from three different microsphere formulations demonstrated initial burst effects ranging from 28.2% to 54.7% after a 1-day incubation and exhibited no further significant releases up to 19 days. This was because the encapsulated rhGH with the microspheres was largely aggregated in a non-covalent fashion during the formulation. Nonaggregated water soluble rhGH species within the microspheres are likely to be responsible for the rapid release upon incubation. The initially released rhGH in the incubation medium, however, was composed of mostly monomer species with a small amount of dimer as probed by size-exclusion chromatography. Circular dichroism spectra of the initially released rhGH in the medium revealed that the conformation of the released rhGH was correctly folded relative to that of native rhGH, with little variation in α-helix contents depending on the formulations. The `nonrelease' mechanism after the initial burst release was attributed to nonspontaneously dissociable noncovalent protein aggregation and surface adsorption of IhGH present within the microspheres.
AB - Recombinant human growth hormone (rhGH) was encapsulated within poly(D,L-lactic-co-glycolic acid) microspheres by a double emulsion solvent evaporation method. A mixture of methylene chloride and ethyl acetate in varying volume ratios was used for the micro-sphere preparation. Protein release profiles from three different microsphere formulations demonstrated initial burst effects ranging from 28.2% to 54.7% after a 1-day incubation and exhibited no further significant releases up to 19 days. This was because the encapsulated rhGH with the microspheres was largely aggregated in a non-covalent fashion during the formulation. Nonaggregated water soluble rhGH species within the microspheres are likely to be responsible for the rapid release upon incubation. The initially released rhGH in the incubation medium, however, was composed of mostly monomer species with a small amount of dimer as probed by size-exclusion chromatography. Circular dichroism spectra of the initially released rhGH in the medium revealed that the conformation of the released rhGH was correctly folded relative to that of native rhGH, with little variation in α-helix contents depending on the formulations. The `nonrelease' mechanism after the initial burst release was attributed to nonspontaneously dissociable noncovalent protein aggregation and surface adsorption of IhGH present within the microspheres.
KW - Controlled release
KW - Human growth hormone
KW - Microspheres
KW - PLGA
KW - Protein aggregation stability
UR - http://www.scopus.com/inward/record.url?scp=0001719160&partnerID=8YFLogxK
U2 - 10.1002/(SICI)1097-0290(19991220)65:6<659::AID-BIT6>3.0.CO;2-9
DO - 10.1002/(SICI)1097-0290(19991220)65:6<659::AID-BIT6>3.0.CO;2-9
M3 - Article
C2 - 10550772
AN - SCOPUS:0001719160
SN - 0006-3592
VL - 65
SP - 659
EP - 667
JO - Biotechnology and Bioengineering
JF - Biotechnology and Bioengineering
IS - 6
ER -